支气管哮喘患者自我管理中国专家共识

2018-03-09 中华医学会呼吸病学分会哮喘学组中华结核和呼吸杂志,2018,41(3):171-178.

根据全球支气管哮喘(哮喘)防治创议(GINA)标准定义的哮喘控制水平，2017年最新报道的我国30个省市城区门诊哮喘患者控制水平的流行病学调查结果显示，我国城区哮喘患者的症状控制率只有28.5%，总体控制水平尚不理想。哮喘的治疗目标在于达到哮喘症状的控制，减少急性发作和减少肺功能的不可逆损害等风险。要达到哮喘控制的目标，提高哮喘患者的自我管理水平是非常重要的一环。为了促进我国哮喘患者自我管理，探索

中文标题：

支气管哮喘患者自我管理中国专家共识

发布机构：

中华医学会呼吸病学分会哮喘学组

发布日期：

2018-03-09

简要介绍：

根据全球支气管哮喘(哮喘)防治创议(GINA)标准定义的哮喘控制水平，2017年最新报道的我国30个省市城区门诊哮喘患者控制水平的流行病学调查结果显示，我国城区哮喘患者的症状控制率只有28.5%，总体控制水平尚不理想。哮喘的治疗目标在于达到哮喘症状的控制，减少急性发作和减少肺功能的不可逆损害等风险。要达到哮喘控制的目标，提高哮喘患者的自我管理水平是非常重要的一环。为了促进我国哮喘患者自我管理，探索患者自我管理的路径和方法，中华医学会呼吸病学分会哮喘学组基于2017年GINA和2016年中华医学会呼吸病学分会哮喘学组制定的"支气管哮喘防治指南"等文件，结合国内外循证医学证据和临床经验，制定了适于呼吸专科医生和基层医生临床实践应用的"支气管哮喘患者自我管理中国专家共识"，为临床医生指导哮喘患者进行自我管理提供参考。

拓展指南：与哮喘相关指南：

有关哮喘更多指南

下载附件：

点击下载

(因为版权问题，不支持下载)

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=949830, encodeId=af88949830e1, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364738, encodeId=bcef364e38a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e75077275, createdName=150****7230暂无昵称, createdTime=Tue Apr 16 10:26:52 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297334, encodeId=802629e334b1, content=学习了分享一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Sun Mar 18 08:13:41 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295807, encodeId=ac3e29580e63, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:41 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295420, encodeId=c41f295420be, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:13:10 CST 2018, time=2018-03-12, status=1, ipAttribution=)]
2021-03-20 ms5000001146316601

有用

82 0
[GetPortalCommentsPageByObjectIdResponse(id=949830, encodeId=af88949830e1, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364738, encodeId=bcef364e38a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e75077275, createdName=150****7230暂无昵称, createdTime=Tue Apr 16 10:26:52 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297334, encodeId=802629e334b1, content=学习了分享一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Sun Mar 18 08:13:41 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295807, encodeId=ac3e29580e63, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:41 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295420, encodeId=c41f295420be, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:13:10 CST 2018, time=2018-03-12, status=1, ipAttribution=)]
2019-04-16 150****7230暂无昵称

学习了

111 0
[GetPortalCommentsPageByObjectIdResponse(id=949830, encodeId=af88949830e1, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364738, encodeId=bcef364e38a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e75077275, createdName=150****7230暂无昵称, createdTime=Tue Apr 16 10:26:52 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297334, encodeId=802629e334b1, content=学习了分享一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Sun Mar 18 08:13:41 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295807, encodeId=ac3e29580e63, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:41 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295420, encodeId=c41f295420be, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:13:10 CST 2018, time=2018-03-12, status=1, ipAttribution=)]
2018-03-18 杨利洪

学习了分享一下

103 0
[GetPortalCommentsPageByObjectIdResponse(id=949830, encodeId=af88949830e1, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364738, encodeId=bcef364e38a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e75077275, createdName=150****7230暂无昵称, createdTime=Tue Apr 16 10:26:52 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297334, encodeId=802629e334b1, content=学习了分享一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Sun Mar 18 08:13:41 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295807, encodeId=ac3e29580e63, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:41 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295420, encodeId=c41f295420be, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:13:10 CST 2018, time=2018-03-12, status=1, ipAttribution=)]
2018-03-13 ms2296823935859672

学习了.谢谢分享

102 0
[GetPortalCommentsPageByObjectIdResponse(id=949830, encodeId=af88949830e1, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364738, encodeId=bcef364e38a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e75077275, createdName=150****7230暂无昵称, createdTime=Tue Apr 16 10:26:52 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297334, encodeId=802629e334b1, content=学习了分享一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Sun Mar 18 08:13:41 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295807, encodeId=ac3e29580e63, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:56:41 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295420, encodeId=c41f295420be, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Mar 12 07:13:10 CST 2018, time=2018-03-12, status=1, ipAttribution=)]
2018-03-12 131****1460

学习了受益匪浅

102 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

呼吸指南

支气管哮喘患者自我管理中国专家共识

相关指南

科室

工具

服务